Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Beta lapachone - KT&G Life Sciences

Next Previous
X
Search
Drug Profile

Beta lapachone - KT&G Life Sciences

Alternative Names: MB-12066

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mazence
  • Developer KT&G Life Sciences
  • Class Anti-inflammatories; Antifibrotics; Antineoplastics; Eye disorder therapies; Naphthoquinones; Obesity therapies; Small molecules
  • Mechanism of Action Sirtuin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Non-alcoholic fatty liver disease
  • No development reported Macular degeneration; Metabolic syndrome

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Macular-degeneration in South Korea (PO, Tablet)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Metabolic-syndrome(In volunteers) in South Korea (PO, Tablet)
  • 31 Mar 2015 KT&G Life Sciences terminates phase II trial in Non-alcoholic fatty liver disease in South Korea (NCT02029586) before March 2015

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top